Table 1.
Baseline clinical and biochemical characteristics of all patients
| All | HCV | ASH/NASH | HBV | Cryptogenic | HDV | Other causes | |
| (n = 291) | (n = 92) | (n = 109) | (n = 35) | (n = 13) | (n = 10) | (n = 32) | |
| Age, yr | 54 ± 15 | 59 ± 13b | 53 ± 15 | 51 ± 13b | 59 ± 15 | 43 ± 9a | 50 ± 17a |
| Gender,% | |||||||
| Female | 39.9 | 41.3 | 36.7 | 28.6 | 38.5 | 30 | 59.4a |
| Male | 60.1 | 58.7 | 63.3 | 71.4 | 61.5 | 70 | 40.6 |
| Cirrhosis, % | 62.5 | 76.1 | 56 | 68.6 | 100b | 70 | 25.0d |
| BMI, kg/m² | 25.5 ± 4.2 | 24.6 ± 3.9a | 25.8 ± 4.8 | 27.2 ± 3.3 | 25.3 ± 3.0 | 23.2 ± 4.9 | 25.2 ± 3.6 |
| Bilirubin, mg/dL | 2.7± 4.8 | 1.5 ± 2.5b | 4.3 ± 7.0 | 1.5 ± 1.5b | 1.8 ± 1.3 | 2.0 ± 1.6 | 4.1 ± 5.8 |
| Albumin, g/dL | 3.6 ± 0.7 | 3.8 ± 0.6b | 3.4 ± 0.7a | 3.8 ± 0.7 | 3.4 ± 0.7 | 3.4 ± 0.6 | 3.7 ± 0.4 |
| Immunoglobulins, g/dL | 1.7 ± 0.7 | 1.8 ± 0.7 | 1.5 ± 0.7 | 1.7 ± 0.8 | 1.5 ± 0.4 | 2.6 ± 0.7b | 1.7 ± 0.5 |
| AST, U/L | 116 ± 175 | 100 ± 54 | 113 ± 187 | 76 ± 51 | 70 ± 55 | 155 ± 94 | 243 ± 400 |
| ALT, U/L | 106 ± 176 | 102 ± 71 | 73 ± 100b | 72 ± 52 | 43 ± 20 | 131 ± 62 | 300 ± 462a |
| AFP, μg/L¹ | 6.2 | 9.7 | 5.8 | 3.4 | 5.9 | 7.2 | 2.9 |
| Platelets, a1000/μL | 170 ± 83 | 152 ± 82 | 181 ± 79 | 165 ± 78 | 168 ± 77 | 127 ± 74 | 208 ± 96 |
| Prothrombin time, % | 83 ± 18 | 88 ± 16b | 78 ± 21b | 85 ± 13 | 81 ± 23 | 73 ± 14 | 86 ± 15 |
1Median value.
a
P ≤ 0.05;
b
P ≤ 0.01 vs all other patients. HCV: Hepatitis C virus; HBV: Hepatitis B virus; HDV: Hepatitis D virus; ASH: Alcoholic steatohepatitis; NASH: Non-alcoholic steatohepatitis.